Joseph C. Anderson, MD, FACG, MHCDS, provided a review of the best time to start and stop screening for colorectal cancer (CRC) to detect the cancer early and to prevent unnecessary screening.
Jacob E. Kurlander, MD, MS, of the Veterans Affairs (VA) Center for Clinical Management Research and Michigan Medicine shared data on the largest PPI deprescribing intervention in Veterans, showing that these programs help reduce PPI prescribing, without increasing adverse events.
Nancy Reau, MD, explored COVID-19-related liver disease in severe and long-term COVID-19 infections.
Nicholas J. Zyromski, MD, of Indiana University School of Medicine and Giovanni Marchegiani, MD, PhD, of Verona University Hospital in Italy debate whether post-pancreatectomy acute pancreatitis is a relevant clinical entity, and how to treat it.
DDW 2021 is certified for 421.5 AMA PRA Category 1 Credit(s)™. The deadline to claim CME is Oct. 29, 2021.
Ji Young Bang, MD, provided insight into the gender-based inequities in the field of gastroenterology and gave suggestions for clinicians and institutions to prevent and overcome gender bias.
New data presented by Andy Tien, MD, MS, of Kaiser Permanente Medical Center in Los Angeles points to an increased risk of dying from COVID-19 in liver transplant patients.
ASGE President Klaus Mergener, MD, PhD, MBA, provided an overview of the top research from ASGE being presented at DDW 2021.
Conor P. Delaney, MD, MCh, PhD, explained why it’s essential and how to focus on effective team-based and quality patient-centered care.
Andrea E. Reid, MD, MPH, outlined how medical training and education programs can move in the right direction to address racism, bias and discrimination within the profession.
